Presenilins and APP in neuritic and synaptic plasticity: Implications for the pathogenesis of Alzheimer's disease

NeuroMolecular Medicine

Volumn 2, Issue 2, 2002, Pages 167-196

  Chan, Sic L ^a   Furukawa, Katsutoshi ^a   Mattson, Mark P ^a,b  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Calcium; Glutamate receptors; Hippocampus; Learning and memory; LTP and LTD

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CALCIUM; CARRIER PROTEIN; GLUCOSE TRANSPORTER; GLUTAMATE RECEPTOR; GLUTAMATE TRANSPORTER; NERVE PROTEIN; PRESENILIN 1; PRESENILIN 2; MEMBRANE PROTEIN; PSEN1 PROTEIN, HUMAN;

ALZHEIMER DISEASE; AMINO ACID TRANSPORT; APOPTOSIS; AUTOSOMAL DOMINANT DISORDER; BRAIN ELECTROPHYSIOLOGY; CALCIUM HOMEOSTASIS; CELL ADHESION; DEPRESSION; ENDOPLASMIC RETICULUM; EXOCYTOSIS; GENE MUTATION; GLUCOSE TRANSPORT; HIPPOCAMPUS; HUMAN; ION TRANSPORT; LEARNING; LONG TERM POTENTIATION; MEMBRANE TRANSPORT; MEMORY; MEMORY DISORDER; NERVE CELL DEGENERATION; NERVE CELL PLASTICITY; NERVE FIBER GROWTH; NEUROPATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN INTERACTION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SYNAPSE VESICLE; SYNAPTIC MEMBRANE; TRANSGENIC MOUSE; ANIMAL; CELL MEMBRANE; GENETICS; METABOLISM; MUTATION; NERVE FIBER TRANSPORT; NEURITE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SYNAPSE;

MUS MUSCULUS;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; AXONAL TRANSPORT; CELL MEMBRANE; HUMANS; MEMBRANE PROTEINS; MUTATION; NEURITES; NEURONAL PLASTICITY; PRESENILIN-1; SIGNAL TRANSDUCTION; SYNAPSES;

EID: 0036049185     PISSN: 15351084     EISSN: None     Source Type: Journal    
DOI: 10.1385/NMM:2:2:167     Document Type: Review

References (242)

1. Alves da Costa C., Paitel E., Mattson M. P., Amson R., Telerman A., Ancolio K., and Checler F. (2002) Wild-type and mutated presenilins 2 trigger p53 dependent apoptosis and down-regulate presenilin 1 expression in HEK293 human cells and in murine neurons. Proc. Natl. Acad. Sci. USA 99, 4043-4048.
2. Annaert W. and De Strooper B. (1999) Presenilins: molecular switches between proteolysis and signal transduction. Trends Neurosci. 22, 439-443.
3. Annaert W. G., Esselens C., Baert V., Boeve C., Snellings G., Cupers P., et al. (2001) Interaction with telencephalin and the amyloid precursor protein predicts a ring structure for presenilins. Neuron 32, 579-589.
4. Ashe K. H. (2000) Synaptic structure and function in transgenic APP mice. Ann. NY Acad. Sci. 924, 39-41.
5. Baki L., Marambaud P., Efthimiopoulos S., Georgakopoulos A., Wen P., Cui W., et al. (2001) Presenilin-1 binds cytoplasmic epithelial cadherin, inhibits cadherin/p120 association, and regulates stability and function of the cadherin/catenin adhesion complex. Proc. Natl. Acad. Sci. USA 98, 2381-2386.
6. Barger S. W., Fiscus R. R., Ruth P., Hofmann F., and Mattson M. P. (1995) Role of cyclic GMP in the regulation of neuronal calcium and survival by secreted forms of beta-amyloid precursor. J. Neurochem. 64, 2087-2096.
7. Barger S. W. and Mattson M. P. (1995) The secreted form of the Alzheimer's beta-amyloid precursor protein stimulates a membrane-associated guanylate cyclase. Biochem. J. 311, 45-47.
8. Barger S. W. and Mattson M. P. (1996) Induction of neuroprotective kappa B-dependent transcription by secreted forms of the Alzheimer's beta-amyloid precursor. Mol. Brain Res. 40, 116-126.
9. Barrow P. A., Empson R. M., Gladwell S. J., Anderson C. M., Killick R., Yu X., et al. (2000) Functional phenotype in transgenic mice expressing mutant human presenilin-1. Neurobiol. Dis. 7, 119-126.
10. Begley J. G., Duan W., Chan S., Duff K., and Mattson M. P. (1999) Altered calcium homeostasis and mitochondrial dysfunction in cortical synaptic compartments of presenilin-1 mutant mice. J. Neurochem. 72, 1030-1039.
11. Beher D., Hesse L., Masters C. L., and Multhaup G. (1996) Regulation of amyloid protein precursor (APP) binding to collagen and mapping of the binding sites on APP and collagen type I. J. Biol. Chem. 271, 1613-1620.
12. Behrens J., Jerchow B. A., Wurtele M., Grimm J., Asbrand C., Wirtz R., et al. (1998) Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. Science 280, 596-599.
13. Behrens J., von Kries J. P., Kuhl M., Bruhn L., Wedlich D., Grosschedl R., et al. (1996) Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 382, 638-642.
14. Berezovska O., Frosch M., McLean P., Knowles R., Koo E., Kang D., et al. (1999) The Alzheimer-related gene presenilin 1 facilitates notch 1 in primary mammalian neurons. Mol. Brain Res. 69, 273-280.
15. Blanc E. M., Kelly J. F., Mark R. J., and Mattson M. P. (1997) 4-hydroxynonenal, an aldehydic product of lipid peroxidation, impairs signal transduction associated with muscarinic acetylcholine and metabotropic glutamate receptors: possible action on Gαq/11. J. Neurochem. 69, 570-580.
16. Borg J. P., Straight S. W., Kaech S. M., de Taddeo-Borg M., Kroon D. E., Karnak D., et al. (1998) Identification of an evolutionarily conserved heterotrimeric protein complex involved in protein targeting. J. Biol. Chem. 273, 31,633-31,636.
17. Bozdagi O., Shan W., Tanaka H., Benson D. L., and Huntley G. W. (2000) Increasing numbers of synaptic puncta during late-phase LTP: N-cadherin is synthesized, recruited to synaptic sites, and required for potentiation. Neuron 28, 245-259.
18. Bruce-Keller A. J., Li Y. J., Lovell M. A., Kraemer P. J., Gary D. S., Brown R. R., et al. (1998) 4-Hydroxynonenal, a product of lipid peroxidation, damages cholinergic neurons and impairs visuospatial memory in rats. J. Neuropathol. Exp. Neurol. 57, 257-267.
19. Bruce-Keller A. J., Umberger G., McFall R., and Mattson M. P. (1999) Food restriction reduces brain damage and improves behavioral outcome following excitotoxic and metabolic insults. Ann. Neurol. 45, 8-15.
20. Buxbaum J. D., Choi E. K., Luo Y., Lilliehook C., Crowley A. C., Merriam D. E., et al. (1998b) Calsenilin: a calcium-binding protein that interacts with the presenilins and regulates the levels of a presenilin fragment. Nat. Med. 4, 1177-1181.
21. Cao X. and Sudhof T. C. (2001) A transcriptionally active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 293, 115-120.
22. Cataldo A. M., Peterhoff C. M., Troncoso J. C., Gomez-Isla T., Hyman B. T., and Nixon R. A. (2000) Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. Am. J. Pathol. 157, 277-286.
23. Chan S. L. and Mattson M. P. (1999) Caspase and calpain substrates: roles in synaptic plasticity and cell death. J. Neurosci. Res. 58, 167-190.
24. Chan S. L., Mayne M., Holden C. P., Geiger J. D., and Mattson M. P. (2000) Presenilin-1 mutations increase levels of ryanodine receptors and calcium release in PC12 cells and cortical neurons. J. Biol. Chem. 275, 18,195-18,200.
25. Chapman P. F., White G. L., Jones M. W., Cooper-Blacketer D., Marshall V. J., Irizarry M., et al. (1999) Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat. Neurosci. 2, 271-276.
26. Chen Q. S., Kagan B. L., Hirakura Y., and Xie C. W. (2000) Impairment of hippocampal long-term potentiation by Alzheimer amyloid β beta-peptide. J. Neurosci. Res. 60, 65-72.
27. Chen Q. S., Wei W. Z., Shimahara T., and Xie C. W. (2002) Alzheimer amyloid beta-peptide inhibits the late phase of long-term potentiation through calcineurin-dependent mechanisms in the hippocampal dentate gyrus. Neurobiol. Learn. Mem. 77, 354-371.
28. Cheng G., Yu Z., Zhou D., and Mattson M. P. (2002) Phosphatidylinositol-3-kinase - Akt and p42/p44 mitogen-activated protein kinases mediate neurotrophic and excitoprotective actions of a secreted form of amyloid precursor protein. Exp. Neurol. 175, 407-414.
29. Cook D. G., Sung J. C., Golde T. E., Felsenstein K. M., Wojczyk B. S., Tanzi R. E., et al. (1996) Expression and analysis of presenilin 1 in a human neuronal system: localization in cell bodies and dendrites. Proc. Natl. Acad. Sci. USA 93, 9223-9228.
30. Cotman C. W., Hailer N. P., Pfister K. K., Soltesz I., and Schachner M. (1998) Cell adhesion molecules in neural plasticity and pathology: similar mechanisms, distinct organizations? Prog. Neurobiol. 55, 659-669.
31. Coulson E. J., Barrett G. L., Storey E., Bartlett P. F., Beyreuther K., and Masters C. L. (1997) Down-regulation of the amyloid protein precursor of Alzheimer's disease by antisense oligonucleotides reduces neuronal adhesion to specific substrata. Brain Res. 770, 72-80.
32. Cullen W.K., Wu J., Anwyl R., and Rowan M. (1996) Beta-Amyloid produces a delayed NMDA receptor-dependent reduction in synaptic transmission in rat hippocampus. Neuroreport 8, 87-92.
33. Cullen W. K., Suh Y. H., Anwyl R., and Rowan M. J. (1997) Block of LTP in rat hippocampus in vivo by Beta-amyloid precursor protein fragments. Neuroreport 8, 3213-3217.
34. Davidsson P., Bogdanovic N., Lannfelt L., and Blennow K. (2001) Reduced expression of amyloid precursor protein, presenilin-1 and rab3a in cortical brain regions in Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 12, 243-250.
35. Dawson G. R., Seabrook G. R., Zheng H., Smith D. W., Graham S., O'Dowd G., et al. (1999) Age-related cognitive deficits, impaired long-term potentiation and reduction in synaptic marker density in mice lacking the beta-amyloid precursor protein. Neuroscience 90, 1-13.
36. DeKosky S. T., Scheff S. W., and Styren S. D. (1996) Structural correlates of cognition in dementia: quantification and assessment of synapse change. Neurodegeneration 5, 417-421.
37. Dewachter I., Reverse D., Caluwaerts N., Ris L., Kuiperi C., Van den Haute C., et al. (2002) Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice. J. Neurosci. 22, 3445-3453.
38. Dowjat W. K., Wisniewski H., and Wisniewski T. (2001) Alzheimer's disease presenilin-1 expression modulates the assembly of neurofilaments. Neuroscience 103, 1-8.
39. Doyle E., Bruce M. T., Breen K. C., Smith D. C., Anderton B., and Regan C. M. (1990) Intraventricular infusions of antibodies to amyloid-beta-protein precursor impair the acquisition of a passive avoidance response in the rat. Neurosci. Lett. 115, 97-102.
40. Dumanchin C., Czech C., Campion D., Cuif M. H., Poyot T., Martin C., et al. (1999) Presenilins interact with Rab11, a small GTPase involved in the regulation of vesicular transport. Hum. Mol. Genet. 8, 1263-1269.
41. Efthimiopoulos S., Floor E., Georgakopoulos A., Shioi J., Cui W., Yasothornsrikul S., et al. (1998) Enrichment of presenilin 1 peptides in neuronal large dense-core and somatodendritic clathrin-coated vesicles. J. Neurochem. 71, 2365-2372.
42. Fagni L., Chavis P., Ango F., and Bockaert J. (2000) Complex interactions between mGluRs, intracellular Ca2+ stores and ion channels in neurons. Trends Neurosci. 23, 80-88.
43. Fakla I., Kovacs I., Yamaguchi H., Geula C., and Kasa P. (2000) Expressions of amyloid precursor protein, synaptophysin and presenilin-1 in the different areas of the developing cerebellum of rat. Neurochem. Int. 36, 143-151.
44. Farber S. A., Nitsch R. M., Schulz J. G., and Wurtman R. J. (1995) Regulated secretion of beta-amyloid precursor protein in rat brain. J. Neurosci. 15, 7442-7451.
45. Fiore F., Zambrano N., Minopoli G., Donini V., Duilio A., and Russo T. (1995) The regions of the Fe65 protein homologous to the phosphotyrosine interaction/phosphotyrosine binding domain of Shc bind the intracellular domain of the Alzheimer's amyloid precursor protein. J. Biol. Chem. 270, 30,853-30,856.
46. Fitzjohn S. M., Morton R. A., Kuenzi F., Davies C. H., Seabrook G. R., and Collingridge G. L. (2000) Similar levels of long-term potentiation in amyloid precursor protein-null and wild-type mice in the CA1 region of picrotoxin treated slices. Neurosci. Lett. 288, 9-12.
47. Fitzjohn S. M., Morton R. A., Kuenzi F., Rosahl T. W., Shearman M., Lewis H., et al. (2001) Age-related impairment of synaptic transmission but normal long-term potentiation in transgenic mice that overexpress the human APP695SWE mutant form of amyloid precursor protein. J. Neurosci. 21, 4691-4698.
48. Franklin J. L., Berechid B. E., Cutting F. B., Presente A., Chambers C. B., Foltz D. R., et al. (1999) Autonomous and non-autonomous regulation of mammalian neurite development by Notch1 and Delta1. Curr. Biol. 9, 1448-1457.
49. Freir D., Holscher C., and Herron C. E. (2001) Blockade of long-term potentiation by Beta-amyloid peptides in the CA1 region of the rat hippocampus in vivo. J. Neurophysiol. 85, 708-713.
50. Furukawa K., Barger S. W., Blalock E. M., and Mattson M. P. (1996a) Activation of K+ channels and suppression of neuronal activity by secreted beta-amyloid-precursor protein. Nature 379, 74-78.
51. Furukawa K., Guo Q., Schellenberg G. D., and Mattson M. P. (1998) Presenilin-1 mutation alters NGF-induced neurite outgrowth, calcium homeostasis, and transcription factor (AP-1) activation in PC12 cells. J. Neurosci. Res. 52, 618-624.
52. Furukawa K., Sopher B. L., Rydel R. E., Begley J. G., Pham D. G., Martin G. M., et al. (1996b) Increased activity-regulating and neuroprotective efficacy of alpha-secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparin-binding domain. J. Neurochem. 67, 1882-1896.
53. Gantier R., Gilbert D., Dumanchin C., Campion D., Davoust D., Toma F., et al. (2000) The pathogenic L392V mutation of presenilin 1 decreases the affinity to glycogen synthase kinase-3 beta. Neurosci. Lett. 283, 217-220.
54. Gao, Y. and Pimplikar S. W. (2001) The gamma-secretase-cleaved C-terminal fragment of amyloid precursor protein mediates signaling to the nucleus. Proc. Natl. Acad. Sci. USA 98, 14,979-14,984.
55. Geddes J. W., Anderson K. J., and Cotman C. W. (1986) Senile plaques as aberrant sprout-stimulating structures. Exp. Neurol. 94, 767-776.
56. Georgakopoulos A., Marambaud P., Efthimiopoulos S., Shioi J., Cui W., Li H. C., et al. (1999) Presenilin-1 forms complexes with the cadherin/catenin cell-cell adhesion system and is recruited to intercellular and synaptic contacts. Mol. Cell 4, 893-902.
57. Gerdeman G. L., Ronesi J., and Lovinger D. M. (2002) Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. Nat. Neurosci. 5, 446-451.
58. Gertler F. B., Niebuhr K., Reinhard M., Wehland J., and Soriano P. (1996) Mena, a relative of VASP and Drosophila Enabled, is implicated in the control of microfilament dynamics. Cell 87, 227-239.
59. Giacchino J., Criado J. R., Games D., and Henriksen S. (2000) In vivo synaptic transmission in young and aged amyloid precursor protein transgenic mice. Brain Res. 876, 185-190.
60. Glazner G. W., Chan S. L., Lu C., and Mattson M. P. (2000) Caspase-mediated degradation of AMPA receptor subunits: a mechanism for preventing excitotoxic necrosis and ensuring apoptosis. J. Neurosci. 20, 3641-3649.
61. Gotz J. (2001) Tau and transgenic animal models. Brain Res. Rev. 35, 266-286.
62. Greenwald I. (1998) LIN-12/Notch signaling: lessons from worms and flies. Genes Dev. 12, 1751-1762.
63. Gunawardena S. and Goldstein L. S. (2001) Disruption of axonal transport and neuronal viability by amyloid precursor protein mutations in Drosophila. Neuron 32, 389-401.
64. Guo Q., Fu W., Sopher B. L., Miller M. W., Ware C. B., Martin G. M., et al. (1999a) Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice. Nat. Med. 5, 101-106.
65. Guo Q., Furukawa K., Sopher B. L., Pham D. G., Xie J., Robinson N., Martin G. M., et al. (1996) Alzheimer's PS-1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid beta-peptide. Neuroreport 8, 379-383.
66. Guo Q., Robinson N., and Mattson M. P. (1998) Secreted beta-amyloid precursor protein counteracts the proapoptotic action of mutant presenilin-1 by activation of NF-kappaB and stabilization of calcium homeostasis. J. Biol. Chem. 273, 12,341-12,351.
67. Guo Q., Sebastian L., Sopher B. L., Miller M. W., Glazner G. W., Ware C. B., et al. (1999c) Neurotrophic factors [activity-dependent neurotrophic factor (ADNF) and basic fibroblast growth factor (bFGF)] interrupt excitotoxic neurodegenerative cascades promoted by a PS1 mutation. Proc. Natl. Acad. Sci. USA 96, 4125-4130.
68. Guo Q., Sebastian L., Sopher B. L., Miller M. W., Ware C. B., Martin G. M., et al. (1999c) Increased vulnerability of hippocampal neurons from presenilin-1 mutant knock-in mice to amyloid beta-peptide toxicity: central roles of superoxide production and caspase activation. J. Neurochem. 72, 1019-1029.
69. Guo Q., Sopher B. L., Furukawa K., Pham D. G., Robinson N., Martin G. M., et al. (1997) Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid beta-peptide: involvement of calcium and oxyradicals. J. Neurosci. 17, 4212-4222.
70. Guo Y., Zhang S. X., Sokol N., Cooley L., and Boulianne G. L. (2000) Physical and genetic interaction of filamin with presenilin in Drosophila. J. Cell Sci. 113, 3499-3508.
71. Guo Z. H. and Mattson M. P. (2000) Neurotrophic factors protect cortical synaptic terminals against amyloid and oxidative stress-induced impairment of glucose transport, glutamate transport and mitochondrial function. Cereb. Cortex 10, 50-57.
72. Hart M. J., de los Santos R., Albert I. N., Rubinfeld B., and Polakis P. (1998). Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta. Curr. Biol. 8, 573-581.
73. Haughey N. J., Liu D., Nath A., Borchard A. C., and Mattson M. P. (2002a) Disruption of neurogenesis in the subventricular zone of adult mice, and in human cortical neuronal precursor cells in culture, by amyloid beta-peptide: implications for the pathogenesis of Alzheimer's disease. Neuromolecular Med. 1, 125-135.
74. Haughey N. J., Nath A., Liu D., Chan S. L., Borchard A. C., Rao M. S., et al. (2002b) Disruption of neurogenesis by amyloid beta-peptide and perturbed calcium homeostasis in models of Alzheimer's disease. J. Neurosci. Submitted.
75. Heber S., Herms J., Gajic V., Hainfellner J., Aguzzi A., Rulicke T., et al. (2000) Mice with combined gene knock-outs reveal essential and partially redundant functions of amyloid precursor protein family members. J. Neurosci. 20, 7951-7963.
76. Herreman A., Serneels L., Annaert W., Collen D., Schoonjans L., and De Strooper B. (2000) Total inactivation of gamma-secretase activity in presenilin-deficient embryonic stem cells. Nat. Cell Biol. 2, 461-462.
77. Hsia A. Y., Masliah E., McConlogue L., Yu G. Q., Tatsuno G., Hu K., et al. (1999) Plaque-independent disruption of neural circuits in Alzheimer's disease mouse model. Proc. Natl. Acad. Sci. USA 96, 3228-3233.
78. Huber G., Martin J. R., Loffler J., and Moreau J. L. (1993) Involvement of amyloid precursor protein in memory formation in the rat: an indirect antibody approach. Brain Res. 603, 348-352.
79. Huber O., Korn R., McLaughlin J., Ohsugi M., Herrmann B. G., and Kemler R. (1996) Nuclear localization of beta-catenin by interaction with transcription factor LEF-1. Mech. Dev. 59, 3-10.
80. Ishida A., Furukawa K., and Mattson M. P. (1997) Secreted form of β-amyloid precursor protein shifts the frequency dependency for induction of LTD, and enhances LTP in hippocampal slices. Neuroreport 8, 2133-2137.
81. Itoh A., Akaike T., Sokabe M., Nitta A., Iida R., Olariu A., et al. (1999) Impairments of long-term potentiation in hippocampal slices of β-amyloid-infused rats. Eur. J. Pharmacol. 382, 167-175.
82. Jensen P. H. and Gai W. P. (2001) Alpha-synuclein. Axonal transport, ligand interaction and neurodegeneration. Adv. Exp. Med. Biol. 487, 129-134.
83. Jin Y. (2002) Synaptogenesis: insights from worm and fly. Curr. Opin. Neurobiol. 12, 71-79.
84. Johnsingh A. A., Johnston J. M., Merz G., Xu J., Kotula L., Jacobsen J. S., et al. (2000) Altered binding of mutated presenilin with cytoskeleton-interacting proteins. FEBS Lett. 465, 53-58.
85. Justice N. J. and Jan Y. N. (2002) Variations on the Notch pathway in neural development. Curr. Opin. Neurobiol. 12, 64-70.
86. Kamal A., Almenar-Queralt A., LeBlanc J. F., Roberts E. A., and Goldstein L. S. (2001) Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP. Nature 414, 643-648.
87. Kang D. E., Soriano S., Frosch M. P., Collins T., Naruse S., Sisodia S. S., et al. (1999) Presenilin 1 facilitates the constitutive turnover of beta catenin: differential activity of Alzheimer's disease-linked PS1 mutants in the beta-catenin signaling pathway. J. Neurosci. 19, 4229-4237.
88. Kawamura Y., Kikuchi A., Takada R., Takada S., Sudoh S., Shibamoto S., et al. (2001) Inhibitory effect of a presenilin 1 mutation on the Wnt signalling pathway by enhancement of beta-catenin phosphorylation. Eur. J. Biochem. 268, 3036-3041.
89. Keller J. N., Pang Z., Geddes J. W., Begley J. G., Germeyer A., Waeg G., et al. (1997) Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid β-peptide: role of the lipid peroxidation product 4-hydroxynonenal. J. Neurochem. 69, 273-284.
90. Kelly J. F., Furukawa K., Barger S. W., Rengen M. R., Mark R. J., Blanc E. M., Roth G. S., and Mattson M. P. (1996) Amyloid beta-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neurons. Proc. Natl. Acad. Sci. USA 93, 6753-6758.
91. Kempermann G. and Gage F. H. (1999) Experience-dependent regulation of adult hippocampal neurogenesis: effects of long-term stimulation and stimulus withdrawal. Hippocampus 9, 321-332.
92. Kesavapany S., Lau K. F., McLoughlin D. M., Brownlees J., Ackerley S., Leigh P. N., et al. (2001) p35/cdk5 binds and phosphorylates beta-catenin and regulates beta-catenin/presenilin-1 interaction. Eur. J. Neurosci. 13, 241-247.
93. Kibbey M. C., Jucker M., Weeks B. S., Neve R. L., Van Nostrand W. E., and Kleinman H. K. (1993) beta-amyloid precursor protein binds to the neurite-promoting IKVAV site of laminin. Proc. Natl. Acad. Sci. USA 90, 10,150-10,153.
94. Kim S. H., Leem J. Y., Lah J. J., Slunt H. H., Levey A. I., Thinakaran G., et al. (2001) Multiple effects of aspartate mutant presenilin 1 on the processing and trafficking of amyloid precursor protein. J. Biol. Chem. 276, 43,343-43,350.
95. Kim T. W., Wu K., Xu J. L., McAuliffe G., Tanzi R. E., Wasco W., et al. (1995) Selective localization of amyloid precursor-like protein 1 in the cerebral cortex postsynaptic density. Mol. Brain Res. 32, 36-44.
96. Kirazov E., Kirazov L., Bigl V., and Schliebs R. (2001) Ontogenetic changes in protein level of amyloid precursor protein (APP) in growth cones and synaptosomes from rat brain and prenatal expression pattern of APP mRNA isoforms in developing rat embryo. Int. J. Dev. Neurosci. 19, 287-296.
97. Kitagawa M., Hatakeyama S., Shirane M., Matsumoto M., Ishida N., Hattori K., et al. (1999) An F-box protein, FWD1, mediates ubiquitin-dependent proteolysis of beta-catenin. EMBO J. 18, 2401-2410.
98. Klintsova A. Y. and Greenough W. T. (1999) Synaptic plasticity in cortical systems. Curr. Opin. Neurobiol. 9, 203-208.
99. Koistinaho M., Ort M., Cimadevilla J. M., Vondrous R., Cordell B., Koistinaho J., et al. (2001) Specific spatial learning deficits become severe with age in beta-amyloid precursor protein transgenic mice that harbor diffuse beta-amyloid deposits but do not form plaques. Proc. Natl. Acad. Sci. USA 98, 14,675-14,680.
100. Koo E.H., Sisodia S. S., Archer D. R., Martin L. J., Weidemann A., Beyreuther K., et al. (1990) Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport. Proc. Natl. Acad. Sci. USA 87, 1561-1565.
101. Korkotian E. and Segal M. (1998) Fast confocal imaging of calcium released from stores in dendritic spines. Eur. J. Neurosci. 10, 2076-2084.
102. Kostyszyn B., Cowburn R. F., Seiger A., Kjaeldgaard A., and Sundstrom E. (2001) Expression of presenilin-1 and Notch-1 receptor in human embryonic CNS. Neuroscience 103, 885-898.
103. Lambert M. P., Barlow A. K., Chromy B. A., Edwards C., Freed R., Liosatos M., et al. (1998) Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. USA 95, 6448-6453.
104. Lantz V. A. and Miller K. G. (1998) A class VI unconventional myosin is associated with a homologue of a microtubule-binding protein, cytoplasmic linker protein-170, in neurons and at the posterior pole of Drosophila embryos. J. Cell Biol. 140, 897-910.
105. Larson J., Lynch G., Games D., and Seubert P. (1999) Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP mice. Brain Res. 840, 23-35.
106. Lau K. F., McLoughlin D. M., Standen C., and Miller C. C. (2000) Xll alpha and x11 beta interact with presenilin-1 via their PDZ domains. Mol. Cell. Neurosci. 16, 557-565.
107. LeBlanc A. C., Kovacs D. M., Chen H. Y., Villare F., Tykocinski M., Autilio-Gambetti L., et al. (1992) Role of amyloid precursor protein (APP): study with antisense transfection of human neuroblastoma cells. J. Neurosci. Res. 31, 635-645.
108. Lee H. J., Jung K. M., Huang Y. Z., Bennett L. B., Lee J. S., Mei L., et al. (2002) Presenilin-dependent gamma-secretase-like intramembrane cleavage of ErbB4. J. Biol. Chem. 277, 6318-6323.
109. Lee J., Seroogy K. B., and Mattson M. P. (2002) Dietary restriction enhances neurotrophin expression and neurogenesis in the hippocampus of adult mice. J. Neurochem. 80, 539-547.
110. Lee M. S., Kwon Y. T., Li M., Peng J., Friedlander R. M., and Tsai L. H. (2000) Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405, 360-364.
111. Leem J. Y., Vijayan S., Han P., Cai D., Machura M., Lopes K. O., et al. (2002) Presenilin 1 is required for maturation and cell surface accumulation of nicastrin. J. Biol. Chem. 277, 19,236-19,240.
112. Leissring M. A., Akbari Y., Fanger C. M., Cahalan M. D., Mattson M. P., and LaFerla F. M. (2000) Capacitative calcium entry deficits and elevated luminal calcium content in mutant presenilin-1 knockin mice. J. Cell Biol. 149, 793-798.
113. Leissring M. A., Murphy M. P., Mead T. R., Akbari Y., Sugarman M. C., Jannatipour M., et al. (2002) A physiologic signaling role for the gamma-secretase-derived intracellular fragment of APP. Proc. Natl. Acad. Sci. USA 99, 4697-4702.
114. Leroy K. and Brion J. P. (1999) Developmental expression and localization of glycogen synthase kinase-3beta in rat brain. J. Chem. Neuroanat. 16, 279-293.
115. Levesque G., Yu G., Nishimura M., Zhang D. M., Levesque L., et al. (1999) Presenilins interact with armadillo proteins including neural-specific plakophilin-related protein and beta-catenin. J. Neurochem. 72, 999-1008.
116. Lewis J., Dickson D. W., Lin W. L., Chisholm L., Corral A., Jones G., et al. (2001) Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293, 1487-1491.
117. Lilliehook C., Chan S., Choi E. K., Zaidi N. F., Wasco W., Mattson M. P., et al. (2002) Calsenilin enhances apoptosis by altering endoplasmic reticulum calcium signaling. Mol. Cell. Neurosci. 19, 552-559.
118. Lorenzo A., Yuan M., Zhang Z., Paganetti P. A., Sturchler-Pierrat C., Staufenbiel M., et al. (2000) Amyloid beta interacts with the amyloid precursor protein: a potential toxic mechanism in Alzheimer's disease. Nat. Neurosci. 3, 460-464.
119. Lucas J. J., Hernandez F., Gomez-Ramos P., Moran M. A., Hen R., and Avila J. (2001) Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. EMBO J. 20, 27-39.
120. Marambaud P, Shioi J., Serban G., Georgakopoulos A., Sarner S., Nagy V., et al. (2002) Apresenilin-1/gamma-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions. EMBO J. 21,1948-1956.
121. Mark R. J., Hensley K., Butterfield D. A., and Mattson M. P. (1995) Amyloid beta-peptide impairs ion-motive ATPase activities: evidence for a role in loss of neuronal Ca2+ homeostasis and cell death. J. Neurosci. 15, 6239-6249.
122. Mark R. J., Lovell M. A., Markesbery W. R., Uchida K., and Mattson M. P. (1997a) A role for 4-hydroxynonenal in disruption of ion homeostasis and neuronal death induced by amyloid β-peptide. J. Neurochem. 68, 255-264.
123. Mark R. J., Pang Z., Geddes J. W., Uchida K., and Mattson M. P. (1997b) Amyloid β-peptide impairs glucose uptake in hippocampal and cortical neurons: involvement of membrane lipid peroxidation. J. Neurosci. 17, 1046-1054.
124. Masliah E. (1995) Mechanisms of synaptic dysfunction in Alzheimer's disease. Histol. Histopathol. 10, 509-519.
125. Masliah E., Mallory M., Hansen L., DeTeresa R., Alford M., and Terry R. (1994) Synaptic and neuritic alterations during the the progression of Alzheimer's disease. Neurosci. Lett. 174, 67-72.
126. Mattson M. P. (1990) Antigenic changes similar to those seen in neurofibrillary tangles are elicited by glutamate and Ca2+ influx in cultured hippocampal neurons. Neuron 4, 105-117.
127. Mattson M. P., Engle M. G., and Rychlik B. (1991) Effects of elevated intracellular calcium levels on the cytoskeleton and tau in cultured human cortical neurons. Mol. Chem. Neuropathol. 15, 117-142.
128. Mattson M. P., Cheng B., Davis D., Bryant K., Lieberburg I., and Rydel R. E. (1992) beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12, 376-389.
129. Mattson M. P., Cheng B., Culwell A. R., Esch F. S., Lieberburg I., and Rydel R. E. (1993a) Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the beta-amyloid precursor protein. Neuron 10, 243-254.
130. Mattson M. P., Barger S. W., Cheng B., Lieberburg I., Smith-Swintosky V. L., and Rydel R. E. (1993b) beta-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease. Trends Neurosci. 16, 409-414.
131. Mattson M. P. (1994) Secreted forms of beta-amyloid precursor protein modulate dendrite outgrowth and calcium responses to glutamate in cultured embryonic hippocampal neurons. J. Neurobiol. 25, 439-450.
132. Mattson M. P. and Begley, J. G. (1996) Amyloid β-peptide alters thrombin-induced calcium responses in cultured human neural cells. Amyloid 3, 28-40.
133. Mattson M. P., Fu W., Waeg G., and Uchida K. (1997) 4-Hydroxynonenal, a product of lipid peroxidation, inhibits dephosphorylation of the microtubule-associated protein tau. Neuroreport 8, 2275-2281.
134. Mattson M. P. (1997) Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol. Rev. 77, 1081-1132.
135. Mattson M. P., Keller J. N., and Begley J. G. (1998a) Evidence for synaptic apoptosis. Exp. Neurol. 153, 35-48.
136. Mattson M. P., Partin J., and Begley J. G. (1998b) Amyloid beta-peptide induces apoptosis-related events in synapses and dendrites. Brain Res. 807, 167-176.
137. Mattson M. P. and Furukawa K. (1998) Signaling events regulating the neurodevelopmental triad. Glutamate and secreted forms of beta-amyloid precursor protein as examples. Perspect. Dev. Neurobiol. 5, 337-352.
138. Mattson M. P., Guo Z. H., and Geiger J. D. (1999) Secreted form of amyloid precursor protein enhances basal glucose and glutamate transport and protects against oxidative impairment of glucose and glutamate transport in synaptosomes by a cyclic GMP-mediated mechanism. J. Neurochem. 73, 532-537.
139. Mattson M. P. and Duan W. (1999) "Apoptotic" biochemical cascades in synaptic compartments: roles in adaptive plasticity and neurodegenerative disorders. J. Neurosci. Res. 58, 152-166.
140. Mattson M. P. (2000) Apoptosis in neurodegenerative disorders. Nat. Rev. Mol. Cell Biol. 1, 120-129.
141. Mattson M. P., LaFerla F. M., Chan S. L., Leissring M. A., Shepel P. N., and Geiger J. D. (2000a) Calcium signaling in the ER: its role in neuronal plasticity and neurodegenerative disorders. Trends Neurosci. 23, 222-229.
142. Mattson M. P., Zhu H., Yu J., and Kindy M. S. (2000b) Presenilin-1 mutation increases neuronal vulnerability to focal ischemia in vivo and to hypoxia and glucose deprivation in cell culture: involvement of perturbed calcium homeostasis. J. Neurosci. 20, 1358-1364.
143. Mattson M. P. and Chan S. L. (2001) Dysregulation of cellular calcium homeostasis in Alzheimer's disease: bad genes and bad habits. J. Mol. Neurosci. 17, 205-224.
144. Mattson M. P., Chan S. L., and Camandola S. (2001) Presenilin mutations and calcium signaling defects in the nervous and immune systems. Bioessays 23, 733-744.
145. McConlogue L., Castellano F., deWit C., Schenk D., and Maltese W. A. (1996) Differential effects of a Rab6 mutant on secretory versus amyloidogenic processing of Alzheimer's beta-amyloid precursor protein. J. Biol. Chem. 271, 1343-1348.
146. McEwen B. S. (2001) Plasticity of the hippocampus: adaptation to chronic stress and allostatic load. Ann. NY Acad. Sci. 933, 265-277.
147. Meziane H., Dodart J. C., Mathis C., Little S., Clemens J., Paul S. M., et al. (1998) Memory-enhancing effects of secreted forms of the beta-amyloid precursor protein in normal and amnestic mice. Proc. Natl. Acad. Sci. USA 95, 12,683-12,688.
148. Miele L. and Osborne B. (1999) Arbiter of differentiation and death: Notch signaling meets apoptosis. J. Cell. Physiol. 181, 393-409.
149. Mileusnic R., Lancashire C. L., Johnston A. N., and Rose S. P. (2000) APP is required during an early phase of memory formation. Eur. J. Neurosci. 12, 4487-4495.
150. Moechars D., Dewachter I., Lorent K., Reverse D., Baekelandt V., Naidu A., et al. (1999) Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J. Biol. Chem. 274, 6483-6492.
151. Morfini G., Szebenyi, G., Elluru, R., Ratner, N., and Brady, S.T. (2002) Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility. EMBO J. 21, 281-293.
152. Mouton J., Marty I., Villaz M., Feltz A., and Maulet Y. (2001) Molecular interaction of dihydropyridine receptors with type-1 ryanodine receptors in rat brain. Biochem. J. 354, 597-603.
153. Mucke L., Masliah E., Johnson W. B., Ruppe M. D., Alford M., Rockenstein E. M., et al. (1994) Synaptotrophic effects of human amyloid beta protein
154. Muller U., Cristina N., Li Z. W., Wolfer D. P., Lipp H. P., Rulicke T., et al. (1994) Behavioral and anatomical deficits in mice homozygous for a modified beta-amyloid precursor protein gene. Cell 79, 755-765.
155. Mungarro-Menchaca X., Ferrera P., Moran J., and Aria C. (2002). B-amyloid peptide induces ultrastructural changes in synaptosomes and potentiates mitochondrial dysfunction in the presence of ryanodine. J. Neurosci. Res. 68, 89-96.
156. Murayama M., Tanaka S., Palacino J., Murayama O., Honda T., Sun X., et al. (1998) Direct association of presenilin-1 with beta-catenin. FEBS Lett. 433, 73-77.
157. Murer M. G., Yan Q., and Raisman-Vozari R. (2001) Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease. Prog. Neurobiol. 63, 171-124.
158. Nagafuchi A. and Takeichi M. (1989) Transmembrane control of cadherin-mediated cell adhesion: a 94 kDa protein functionally associated with a specific region of the cytoplasmic domain of E-cadherin. Cell Regul. 1, 37-44.
159. Nakagawa T. and Yuan J. (2000) Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis. J. Cell Biol. 150, 887-894.
160. Nalbantoglu J., Tirado-Santiago G., Lahsaini A., Poirier J., Goncalves O., Verge G., et al. (1997) Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein. Nature 387, 500-505.
161. Naruse S., Thinakaran G., Luo J. J., Kusiak J. W., Tomita T., Iwatsubo T., et al. (1998) Effects of PS1 deficiency on membrane protein trafficking in neurons. Neuron 21, 1213-1221.
162. Nishimoto I., Okamoto T., Matsuura Y., Takahashi S., Okamoto T., Murayama Y., et al. (1993) Alzheimer amyloid protein precursor complexes with brain GTP-binding protein G(o). Nature 362, 75-79.
163. Nishimura M., Yu G., Levesque G., Zhang D. M., Ruel L., Chen F., et al. (1999) Presenilin mutations associated with Alzheimer disease cause defective intracellular trafficking of beta-catenin, a component of the presenilin protein complex. Nat. Med. 5, 164-169.
164. Nitsch R. M., Farber S. A., Growdon J. H., and Wurtman R. J. (1993) Release of amyloid β-protein precursor derivatives by electrical depolarization of rat hippocampal slices. Proc. Natl. Acad. Sci. USA 90, 5191-5193.
165. Nitsch R. M., Slack B. E., Wurtman R. J., and Growdon J. W. (1992) Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science 258, 304-307.
166. Nitta A., Itoh A., Hasegawa T., and Nabeshima T. (1994) beta-Amyloid protein-induced Alzheimer's disease animal model. Neurosci. Lett. 170, 63-66.
167. Niwa M., Sidrauski C., Kaufman R. J., and Walter P. (1999) A role for presenilin-1 in nuclear accumulation of Ire1 fragments and induction of the mammalian unfolded protein response. Cell 99, 691-702.
168. Noll E., Medina M., Hartley D., Zhou J., Perrimon N., and Kosik K. S. (2000) Presenilin affects arm/beta-catenin localization and function in Drosophila. Dev. Biol. 227, 450-464.
169. Nottebohm F. (2002) Neuronal replacement in adult brain. Brain Res. Bull. 57, 737-749.
170. Novak A. and Dedhar S. (1999) Signaling through beta-catenin and Lef/Tcf. Cell. Mol. Life Sci. 56, 523-537.
171. Ohsawa I., Takamura C., Morimoto T., Ishiguro M., and Kohsaka S. (1999) Amino-terminal region of secreted form of amyloid precursor protein stimulates proliferation of neural stem cells. Eur. J. Neurosci. 11, 1907-1913.
172. Osen-Sand A., Staple J. K., Naldi E., Schiavo G., Rossetto O., Petitpierre S., et al. (1996) Common and distinct fusion proteins in axonal growth and transmitter release. J. Comp. Neurol. 367, 222-234.
173. Ozawa M. and Kemler R. (1998) Altered cell adhesion activity by pervanadate due to the dissociation of alpha-catenin from the E-cadherin. catenin complex. J. Biol. Chem. 273, 6166-6170.
174. Parent A., Linden D. J., Sisodia S. S., and Borchelt D. R. (1999) Synaptic transmission and hippocampal long-term potentiation in transgenic mice expressing FAD-linked presenilin 1. Neurobiol. Dis. 6, 56-62.
175. Patapoutian A. and Reichardt L. F. (2000) Roles of Wnt proteins in neural development and maintenance. Curr. Opin. Neurobiol. 10, 392-399.
176. Patrick G. N., Zukerberg L., Nikolic M., de la Monte S., Dikkes P., and Tsai L. H. (1999) Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402, 615-622.
177. Pedersen W. A., Chan S. L., and Mattson M. P. (2000) A mechanism for the neuroprotective effect of apolipoprotein E: isoform-specific modification by the lipid peroxidation product 4-hydroxynonenal. J. Neurochem. 74, 1426-1433.
178. Pei J. J., Braak E., Braak H., Grundke-Iqbal I., Iqbal K., Winblad B., and Cowburn R. F. (1999) Distribution of active glycogen synthase kinase 3beta (GSK3beta) in brains staged for Alzheimer disease neurofibrillary changes. J. Neuropathol. Exp. Neurol. 58, 1010-1019.
179. Pei J. J., Tanaka T., Tung Y. C., Braak E., Iqbal K., and Grundke-Iqbal I. (1997) Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain. J. Neuropathol. Exp. Neurol. 56, 70-78.
180. Perez R. G., Zheng H., Van der Ploeg L. H., and Koo E. H. (1997) The beta-amyloid precursor protein of Alzheimer's disease enhances neuron viability and modulates neuronal polarity. J. Neurosci. 17, 9407-9414.
181. Phillips H. S., Hains J. M., Armanini M., Laramee G. R., Johnson S. A., and Winslow J. W. (1991) BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease. Neuron 7, 695-702.
182. Pigino G., Pelsman A., Mori H., and Busciglio J. (2001) Presenilin-1 mutations reduce cytoskeletal association, deregulate neurite growth, and potentiate neuronal dystrophy and tau phosphorylation. J. Neurosci. 21, 834-842.
183. Pradier L., Carpentier N., Delalonde L., Clavel N., Bock M. D., Buee L., et al. (1999) Mapping the APP/presenilin (PS) binding domains: the hydrophilic N-terminus of PS2 is sufficient for interaction with APP and can displace APP/PS1 interaction. Neurobiol. Dis. 6, 43-55.
184. Prolla T. A. and Mattson M. P. (2001) Molecular mechanisms of brain aging and neurodegenerative disorders: lessons from dietary restriction. Trends Neurosci. 24, S21-S31.
185. Querfurth H. W. and Selkoe D. J. (1994) Calcium ionophore increases amyloid beta peptide production by cultured cells. Biochemistry 33, 550-4561.
186. Rao M. S. and Mattson M. P. (2001) Stem cells and aging: expanding the possibilities. Mech. Ageing Dev. 122, 713-734.
187. Ray W. J., Yao M., Nowotny P., Mumm J., Zhang W., Wu J. Y., Kopan R., et al. (1999) Evidence for a physical interaction between presenilin and Notch. Proc. Natl. Acad. Sci. USA 96, 3263-3268.
188. Redmond L., Oh S. R., Hicks C., Weinmaster G., and Ghosh A. (2000) Nuclear Notch1 signaling and the regulation of dendritic development. Nat. Neurosci. 3, 30-40.
189. Ribaut-Barassin C., Moussaoui S., Brugg B., Haeberle A. M., Huber G., Imperato A., et al. (2000) Hemisynaptic distribution patterns of presenilins and beta-APP isoforms in the rodent cerebellum and hippocampus. Synapse 35, 96-110.
190. Roch J. M., Masliah E., Roch-Levecq A. C., Sundsmo M. P., Otero D. A., Veinbergs I., et al. (1994) Increase of synaptic density and memory retention by a peptide representing the trophic domain of the amyloid beta/A4 protein precursor. Proc. Natl. Acad. Sci. USA 91, 7450-7454.
191. Rubinfeld B., Albert I., Porfiri E., Fiol C., Munemitsu S., and Polakis P. (1996) Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. Science 272, 1023-1026.
192. Sabo S. L., Ikin A. F., Buxbaum J. D., and Greengard P. (2001) The Alzheimer amyloid precursor protein (APP) and FE65, an APP-binding protein, regulate cell movement. J. Cell Biol. 153, 1403-1414.
193. Saleshando G. and O'Connor J. J. (2000) SB203580, the p38 mitogen-activated protein kinase inhibitor blocks the inhibitory effect of beta-amyloid on long-term potentiation in the rat hippocampus. Neurosci. Lett. 288, 119-122.
194. Salinska E. J., Bourne R. C., and Rose S. P. (2001) Long-term memory formation in the chick requires mobilization of ryanodine-sensitive intracellular calcium stores. Neurobiol. Learn. Mem. 75, 293-302.
195. Sapp E., Penney J., Young A., Aronin N., Vonsattel J. P., and DiFiglia M. (1999) Axonal transport of N-terminal huntingtin suggests early pathology of corticostriatal projections in Huntington disease. J. Neuropathol. Exp. Neurol. 58, 165-173.
196. Sastre M., Steiner H., Fuchs K., Capell A., Multhaup G., Condron M. M., et al. (2001) Presenilin-dependent gamma-secretase processing of beta-amyloid precursor protein at a site corresponding to the S3 cleavage of Notch. EMBO J. Rep. 2, 835-841.
197. Scheper W., Zwart R., Sluijs P., Annaert W., Gool W. A., and Baas F. (2000) Alzheimer's presenilin 1 is a putative membrane receptor for rab GDP dissociation inhibitor. Hum. Mol. Genet. 9, 303-310.
198. Schneider I., Reverse D., Dewachter I., Ris L., Caluwaerts N., Kuiperi C., et al. (2001) Mutant presenilins disturb neuronal calcium homeostasis in the brain of transgenic mice, decreasing the threshold for excitotoxicity and facilitating long-term potentiation. J. Biol. Chem. 276, 11,539-11,544.
199. Schroeter E. H., Kisslinger J. A., and Kopan R. (1998) Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. Nature 393, 382-386.
200. Schubert W., Prior R., Weidemann A., Dircksen H., Multhaup G., Masters C. L., et al. (1991) Localization of Alzheimer beta A4 amyloid precursor protein at central and peripheral synaptic sites. Brain Res. 563, 184-194.
201. Schuman E. M. and Madison D. V. (1991) A requirement for the intercellular messenger nitric oxide in long-term potentiation. Science 254, 1503-1506.
202. Seabrook G. R., Smith D. W., Bowery B. J., Easter A., Reynolds T., Fitzjohn S. M., et al. (1999) Mechanisms contributing to the deficits in hippocampal synaptic plasticity in mice lacking amyloid precursor protein. Neuropharmacology 38, 349-359.
203. Seabrook G. R., Smith D. W., Bowery B. J., Easter A., Reynolds T., Fitzjohn S. M., et al. (1999) Mechanisms contributing to the deficits in hippocampal synaptic plasticity in mice lacking amyloid precursor protein. Neuropharmacology 38, 349-359.
204. See V. and Loeffler J. P. (2001) Oxidative stress induces neuronal death by recruiting a protease and phosphatase-gated mechanism. Biol. Chem. 276, 35,049-35,059.
205. Selkoe D. J. (2001) Presenilin, Notch, and the genesis and treatment of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 98, 11,039-11,041.
206. Sestan N., Artavanis-Tsakonas S., and Rakic P. (1999) Contact-dependent inhibition of cortical neurite growth mediated by notch signaling. Science 286, 741-746.
207. Shen J., Bronson R. T., Chen D. F., Xia W., Selkoe D. J., and Tonegawa S. (1997) Skeletal and CNS defects in Presenilin-1-deficient mice. Cell 89, 629-639.
208. Shimuta M., Yoshikawa M., Fukaya M., Watanabe M., Takeshima H., and Manabe T. (2001) Postsynaptic modulation of AMPA receptor-mediated synaptic responses and LTP by the type 3 ryanodine receptor. Mol. Cell. Neurosci. 17, 921-930.
209. Sisodia S. S., Kim S. H., and Thinakaran G. (1999) Function and dysfunction of the presenilins. Am. J. Hum. Genet. 65, 7-12.
210. Small D. H., Nurcombe V., Reed G., Clarris H., Moir R., Beyreuther K., et al. (1994) A heparin-binding domain in the amyloid protein precursor of Alzheimer's disease is involved in the regulation of neurite outgrowth. J. Neurosci. 14, 2117-2127.
211. Smith S. K., Anderson H. A., Yu G., Robertson A. G., Allen S. J., Tyler S. J., et al. (2000) Identification of syntaxin 1A as a novel binding protein for presenilin-1. Mol. Brain Res. 78, 100-107.
212. Song W., Nadeau P., Yuan M., Yang X., Shen J., and Yankner B. A. (1999) Proteolytic release and nuclear translocation of Notch-1 are induced by presenilin-1 and impaired by pathogenic presenilin-1 mutations. Proc. Natl. Acad. Sci. USA 96, 6959-6963.
213. Soriano S., Kang D. E., Fu M., Pestell R., Chevallier N., Zheng H., et al. (2001) Presenilin 1 negatively regulates beta-catenin/T cell factor/ lymphoid enhancer factor-1 signaling independently of beta-amyloid precursor protein and notch processing. J. Cell Biol. 152, 785-794.
214. Stahl B., Diehlmann A., and Sudhof T. C. (1999) Direct interaction of Alzheimer's disease-related presenilin 1 with armadillo protein p0071. J. Biol. Chem. 274, 9141-9148.
215. Steiner H. and Haass C. (2001) Nuclear signaling: a common function of presenilin substrates? J. Mol. Neurosci. 17, 193-198.
216. Stephan A., Laroche S., and Davis S. (2001) Generation of aggregated beta-amyloid in the rat hippocampus impairs synaptic transmission and plasticity and causes memory deficits. J. Neurosci. 21, 5703-5714.
217. Struhl G. and Greenwald I. (1999) Presenilin is required for activity and nuclear access of notch in Drosophila. Nature 398, 522-525.
218. Sych M., Hartmann H., Steiner B., and Mueller W. E. (2000) Presenilin I interaction with cytoskeleton and association with actin filaments. Neuroreport 11, 3091-3098.
219. Takashima A., Murayama M., Murayama O., Kohno T., Honda T., Yasutake K., et al. (1998) Presenilin 1 associates with glycogen synthase kinase-3beta and its substrate tau. Proc. Natl. Acad. Sci. USA 95, 9637-9641.
220. Tanahashi H. and Tabira T. (1999) Isolation of human delta-catenin and its binding specificity with presenilin 1. Neuroreport 10, 563-568.
221. Tanahashi H. and Tabira T. (1999) X11L2, new member of the X11 protein family, interacts with Alzheimer's beta-amyloid precursor protein. Biochem. Biophys. Res. Commun. 255, 663-667.
222. Tanaka H., Shan W., Phillips G. R., Arndt K., Bozdagi O., Shapiro L., et al. (2000) Molecular modification of N-cadherin in response to synaptic activity. Neuron 25, 93-107.
223. Tang L., Hung C. P., and Schuman E. M. (1998) A role for the cadherin family of cell adhesion molecules in hippocampal long-term potentiation. Neuron 20, 1165-1175.
224. Tesseur I., Van Dorpe J., Bruynseels K., Bronfman F., Sciot R., Van Lommel A., et al. (2000) Prominent axonopathy and disruption of axonal transport in transgenic mice expressing human apolipoprotein E4 in neurons of brain and spinal cord. Am. J. Pathol. 157, 1495-1510.
225. Uemura T. (1998) The cadherin superfamily at the synapse: more members, more missions. Cell 93, 1095-1098.
226. Walsh D. M., Klyubin I., Fadeeva J. V., Cullen W. K., Anwyl R., Wolfe M. S., et al. (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535-539.
227. Wang H. W., Pasternak J. F., Kuo H., Ristic H., Lambert M. P., Chromy B., et al. (2002) Soluble oligomers of β amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus. Brain Res. 924, 133-140.
228. Weihl C. C., Ghadge G. D., Kennedy S. G., Hay N., Miller R. J., and Roos R. P. (1999) Mutant presenilin-1 induces apoptosis and downregulates Akt/PKB. J. Neurosci. 19, 5360-5369.
229. Wong P. C., Zheng H., Chen H., Becher M. W., Sirinathsinghji D. J., Trumbauer M. E., et al. (1997) Presenilin 1 is required for Notch1 and DII1 expression in the paraxial mesoderm. Nature 387, 288-292.
230. Wu J., Anwyl R., and Rowan M. J. (1995) β-Amyloid (1-40) increases long-term potentiation in rat hippocampus in vitro. Eur. J. Pharmacol. 284, R1-R3.
231. Xia W., Zhang J., Perez R., Koo E. H., and Selkoe D. J. (1997) Interaction between amyloid precursor protein and presenilins in mammalian cells: implications for the pathogenesis of Alzheimer disease. Proc. Natl. Acad. Sci. USA 94, 8208-8213.
232. Xu X., Shi Y., Wu X., Gambetti P., Sui D., and Cui M. Z. (1999) Identification of a novel PSD-95/Dlg/ZO-1 (PDZ)-like protein interacting with the C terminus of presenilin-1. J. Biol. Chem. 274, 32,543-32,546.
233. Ye L. and Qiao J. T. (1999) Suppressive action produced by β-amyloid peptide fragment 31-35 on long-term potentiation in rat hippocampus is N-methyl-D-aspartate receptor-independent: it's offset by (-)huperzine A. Neurosci. Lett. 275, 187-190.
234. Yoo A. S., Cheng I., Chung S., Grenfell T. Z., Lee H., Pack-Chung E., et al. (2000) Presenilin-mediated modulation of capacitative calcium entry. Neuron 27, 561-572.
235. Yoshimura H., Sugai T., Onoda N., Segami N., and Kato N. (2002) Age-dependent occurrence of synchronized population oscillation suggestive of a developing functional coupling between NMDA and ryanodine receptors in the neocortex. Brain Res. Dev. Brain Res. 136, 63-68.
236. Yu C., Kim S. H., Ikeuchi T., Xu H., Gasparini L., Wang R., and Sisodia S. S. (2001) Characterization of a presenilin-mediated amyloid precursor protein carboxyl-terminal fragment gamma. Evidence for distinct mechanisms involved in gamma-secretase processing of the APP and Notch1 transmembrane domains. J. Biol. Chem. 276, 43,756-43,760.
237. Zhang W., Han S. W., McKeel D. W., Goate A., and Wu J. Y. (1998a) Interaction of presenilins with the filamin family of actin-binding proteins. J. Neurosci. 18, 914-922.
238. Zhang Z., Hartmann H., Do V. M., Abramowski D., Sturchler-Pierrat C., Staufenbiel M., et al. (1998b) Destabilization of beta-catenin by mutations in presenilin-1 potentiates neuronal apoptosis. Nature 395, 698-702.
239. Zheng H., Jiang M., Trumbauer M. E., Hopkins R., Sirinathsinghji D. J., Stevens K. A., et al. (1996) Mice deficient for the amyloid precursor protein gene. Ann. NY Acad. Sci. 777, 421-426.
240. Zhou J., Liyanage U., Medina M., Ho C., Simmons A. D., Lovett M., et al. (1997) Presenilin 1 interaction in the brain with a novel member of the Armadillo family. Neuroreport 8, 1489-1494.
241. Zhu H., Guo Q., and Mattson M. P. (1999) Dietary restriction protects hippocampal neurons against the death-promoting action of a presenilin-1 mutation. Brain Res. 842, 224-229.
242. Zilberter Y. (2000) Dendritic release of glutamate suppresses synaptic inhibition of pyramidal neurons in rat neocortex. J. Physiol. 528, 489-496.